CUSIP 04216R102COMARMPQ4 2025
23 filings · latest Jan 26, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vanguard Group Inc | 357.6K | $2.25M |
| 2 | 683 Capital Management, LLC | 139.9K | $878.3K |
| 3 | Geode Capital Management, LLC | 109.9K | $690.3K |
| 4 | Edgewood Management LLC | 100.0K | $628.0K |
| 5 | Blackrock, Inc. | 72.8K | $457.0K |
| 6 | Renaissance Technologies LLC | 68.5K | $430.2K |
| 7 | State Street Corp | 50.8K | $319.0K |
| 8 | Goldman Sachs Group Inc | 45.2K | $283.6K |
| 9 |
| 4 | Nov 14, 2024 | Innoviva, Inc. | 13D/A | 85.2% | 64.18M | SEC |
| 5 | Mar 4, 2024 | Innoviva, Inc. | 13D/A | 85.3% | 64.18M | SEC |
| 6 | Jul 11, 2023 | Innoviva, Inc. | 13D/A | 85.3% | 64.18M | SEC |
| 7 | Jan 10, 2023 | Innoviva, Inc. | 13D/A | 85.3% | 64.18M | SEC |
| 8 | Jul 11, 2022 | Innoviva, Inc. | 13D/A | 100.0% | — | SEC |
| 9 | May 24, 2022 | Innoviva, Inc. | 13D/A | 74.9% | 57.35M | SEC |
| 10 | Apr 1, 2022 | Innoviva, Inc. | 13D/A | 80.1% | 44.44M | SEC |
See the full Schedule 13D/13G history for Armata Pharmaceuticals Inc.
Unlock full history| Bridgeway Capital Management, LLC |
| 44.7K |
| $280.6K |
| 10 | Seacrest Wealth Management, LLC | 41.0K | $273.8K |